|
Safety testing of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Laughter & Crying) Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified health advice, visits or treatment with a real mD. We are not doctors. Always consult your doctor about Safety testing of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Laughter & Crying) conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Safety testing of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Laughter & Crying) Clinical research trials and Safety testing of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Laughter & Crying) healthcare trials happen in many of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new drugs. The purpose of the studies / projects is to solve particular human medical questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to discover cures for all varieties of conditions, such as Safety testing of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Laughter & Crying). Safety testing of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Laughter & Crying) Clinical Trials and other clinical trials allow volunteers to have health treatment alternatives before they are available to the masses. Some times the human subjects obtain treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Safety testing of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Laughter & Crying) clinical trial. Test subjects oftentimes receive the most effective healthcare possible for their Safety testing of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Laughter & Crying) condition. Dangers are a reality, however, and may include extra or frequent physician visits, healthcare dangers (possibly life-jeopardising), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Safety testing of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Laughter & Crying) Safety testing of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Laughter & Crying)
Safety testing of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Laughter & Crying)
For Condition: Alzheimer's Disease,Traumatic Brain Injury,Amyotrophic Lateral Sclerosis,Multiple Sclerosis,Stroke
Status: Recruiting
Sponsor(s): Avanir Pharmaceuticals ,
Synopsis: The purpose of this study is to evaluate the safety of AVP-923 for the treatment of emotional lability.
Details:
Eligibility:
Study Type: Interventional, Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety Study
Minimum Age/Maximum Age: 18 Years/75 Years
Genders: Both
Protocol Entry Criteria: Inclusion: - 18 to 75 years of age, inclusive - Clinical diagnosis of pseudobulbar affect - If female, must not be pregnant or breast feeding Exclusion: - Sensitivity to quinidine or any opiate drugs - Current or prior history of major psychiatric disturbance - Currently participated in a trial within the past 30 days
Total Enrollment: 300
Location and Contact Information:
Hospital for Joint Diseases MS Care Center *Recruiting*
New York City, New York, 10003
United States
Recruiting Lisa Capolino 212-598-6118
Carolinas Medical Center *Recruiting*
Charlotte, North Carolina, 28203
United States
Recruiting Ruth King 704-355-8699
Neurological Associates *Recruiting*
Ft. Lauderdale, Florida, 33334
United States
Recruiting Michele Fistel 954-202-1278
MCP-Hahnemann University *Recruiting*
Philadelphia, Pennsylvania, 19107
United States
Recruiting Kellie Lind 215-762-5186
University of Miami Dept. of Neurology *Recruiting*
Miami, Florida, 33136
United States
Recruiting Julie Steele 305-243-7424
Upstate Clinical Research *Recruiting*
Albany, New York, 12205
United States
Recruiting Suzanne Alterman 518-533-1500
Neurological Associates, P.C. *Recruiting*
Lincoln, Nebraska, 68506
United States
Recruiting Kathie Allstot 215-762-5186
Neurology & Headache Specialist of Atlanta, L.L.C. *Recruiting*
Decatur, Georgia, 30033
United States
Recruiting Beverly Johnson-Finley 404-294-3040
Consultants in Neurology LTD *Recruiting*
Northbrook, Illinois, 60062
United States
Recruiting Andrea Corsino 847-509-0270
NeuroCare Center, Inc. *Recruiting*
Canton, Ohio, 44718
United States
Recruiting Fran Duszynski 330-494-2097
UCLA School of Medicine *Not yet recruiting*
Los Angeles, California, 90095
United States
Not yet recruiting Connie Laurel 310-825-9816
UCSF *Recruiting*
San Francisco, California, 94117
United States
Recruiting Marni Hillinger 415-502-5064
Radiant Research, Alexian Brothers *Recruiting*
Elk Grove Village, Illinois, 60007
United States
Recruiting Debra Robinson 847-640-9952
University of Wisconsin *Recruiting*
Madison, Wisconsin, 53792
United States
Recruiting Kathy Roelke 608-262-7175
Penn Neurological Institute *Recruiting*
Philadelphia, Pennsylvania, 19107
United States
Recruiting Mary Kelly 215-829-3709
Westmoreland Neurology *Recruiting*
Greensburg, Pennsylvania, 15601
United States
Recruiting Norma Skillings 724-836-1921
Neurological Associates of Delaware Valley *Recruiting*
Upland, Pennsylvania, 19013
United States
Recruiting Kathleen Dermott 610-876-4800
MetroHealth Medical Center *Recruiting*
Cleveland, Ohio, 44109
United States
Recruiting Alice Liskay 216-778-5420
Swedish Medical Center *Recruiting*
Seattle, Washington, 98122
United States
Recruiting Dennis Kuder 206-215-2027
Renstar Medical Research *Recruiting*
Plantation, Florida, 33324
United States
Recruiting Ellen Amigo 954-915-9991
Barrow Neurological Institute *Recruiting*
Phoenix, Arizona, 85013
United States
Recruiting Louis DiCave 602-406-6292
SUNY Upstate Medical University *Recruiting*
Syracuse, New York, 13210
United States
Recruiting Deborah Kolb 315-464-3935
Raleigh Neurology Associates, PA *Recruiting*
Raleigh, North Carolina, 27607
United States
Recruiting Tippi Garris 919-420-1658
George Washington University Medical Faculty Assoc. *Recruiting*
Washington D.C., District of Columbia, 20037
United States
Recruiting Joseph Choi 202-741-2717
Suncoast Neuroscience Associates Inc. *Recruiting*
St. Petersburg, Florida, 33701
United States
Recruiting Michele Richardson 727-824-7135
DENT Neurologic Group L.L.P. *Recruiting*
Amherst, New York, 14266
United States
Recruiting Roseann Oakes 716-250-2007
Fletcher Allen Health Care *Recruiting*
Burlington, Vermont, 05401
United States
Recruiting Randy Buermann 802-847-4256
Center for Neurologic Study *Recruiting*
La Jolla, California, 92037
United States
Recruiting Emily Adams 858-455-5463
Lehigh Valley Neurosciences and Pain Research Center *Recruiting*
Allentown, Pennsylvania, 18103
United States
Recruiting Nancy Eckert 610-402-9001
Clinical Pharmaceutical Trials, Inc. *Recruiting*
Tulsa, Oklahoma, 74104
United States
Recruiting Jamie Clair 918-743-4374
Margolin Brain Institute *Recruiting*
Fresno, California, 93720
United States
Recruiting J. Margolin 559-299-1515
Neurology and Neurosurgery Associates of Tacoma *Recruiting*
Tacoma, Washington, 98405
United States
Recruiting Susan Kingrey 253-274-1103
Advanced Neurology Specialists *Recruiting*
Great Falls, Montana, 59405
United States
Recruiting Jamie Miller 406-761-8673
Additional Information:
Study ID Numbers: 02-AVR-107; AVP-923
Study Start Date: February 2003
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00056524
Other Multiple Sclerosis Studies:
1. Rolipram to Treat Multiple Sclerosis
2. Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients
3. Natural Antioxidants in the Treatment of Multiple Sclerosis
4. Antibiotic treatment trial directed against Chlamydia pneumonia in multiple sclerosis
5. MR Perfusion Imaging and Hypercapnia (Increased Carbon Dioxide) to Study New Blood Vessel Formation in Multiple Sclerosis
Related Studies:
Other Multiple Sclerosis Clinical Trials
Other California Clinical Trials
Other San Francisco Clinical Trials
Safety testing of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Laughter & Crying)
|
|
|
|
|
|
|
|